RecruitingPhase 1NCT06888193

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

A Multicenter Open-label, Prospective Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Sponsor

UCB Biopharma SRL

Enrollment

20 participants

Start Date

Nov 5, 2025

Study Type

INTERVENTIONAL

Conditions

Hidradenitis Suppurativa Psoriatic Arthritis Axial Spondyloarthritis Moderate to Severe Plaque Psoriasis

Summary

Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Bimekizumab for people with axial spondyloarthritis, hidradenitis suppurativa, and other related conditions. The study is currently recruiting participants at 12 locations. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGBimekizumab

Bimekizumab under the care of their treating physician.

Locations(14)

Up0122 105

Santa Monica, California, United States

Up0122 103

South Miami, Florida, United States

Up0122 104

Boston, Massachusetts, United States

Up0122 106

Chapel Hill, North Carolina, United States

Up0122 102

Durham, North Carolina, United States

Up0122 101

Milwaukee, Wisconsin, United States

Up0122 202

Calgary, Canada

Up0122 201

Vancouver, Canada

Up0122 301

Freiburg im Breisgau, Germany

Up0122 303

Herne, Germany

Up0122 501

Barcelona, Spain

Up0122 502

Barcelona, Spain

Up0122 602

Lausanne, Switzerland

Up0122 601

Sankt Gallen, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06888193

Related Trials

A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis

NCT0740603544 locations

Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

NCT070879122 locations

Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders

NCT071805371 location

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis

NCT0642554950 locations

A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa

NCT0692185018 locations